Edgestream Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,299
Closed -$1.33M 1005
2025
Q4
$1.33M Buy
+5,299
New +$1.41M 0.04% 633
2024
Q2
Sell
-20,567
Closed -$4.49M 956
2024
Q1
$4.49M Buy
+20,567
New +$4.53M 0.22% 140
2021
Q1
Sell
-39,754
Closed -$6.95M 412
2020
Q4
$6.95M Buy
+39,754
New +$6.87M 0.35% 93
2019
Q1
Sell
-10,847
Closed -$1.18M 262
2018
Q4
$1.18M Sell
10,847
-1,617
-13% -$217K 0.21% 130
2018
Q3
$1.86M Buy
+12,464
New +$1.9M 0.32% 109
2018
Q2
Sell
-1,456
Closed -$202K 279
2018
Q1
$202K Sell
1,456
-531
-27% -$78K 0.04% 241
2017
Q4
$272K Sell
1,987
-831
-29% -$110K 0.33% 70
2017
Q3
$365K Buy
+2,818
New +$376K 0.19% 85
2017
Q2
Sell
-8,910
Closed -$1.1M 139
2017
Q1
$1.1M Buy
8,910
+6,823
+327% +$808K 0.48% 46
2016
Q4
$230K Sell
2,087
-4,601
-69% -$511K 0.48% 66
2016
Q3
$790K Buy
+6,688
New +$788K 0.44% 55

Other funds holding LH

Edgestream Partners's LH Position: Q1 2026 in Review

Edgestream Partners sold out of Labcorp (LH) in Q1 2026, closing a stake of 5,299 shares — an estimated $1.33M sold.

Edgestream Partners first reported a position in LH in Q3 2016 and held it in 11 quarters. The position peaked at $6.95M in Q4 2020. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Edgestream Partners reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
  • Edgestream Partners sold 5,299 Labcorp shares in Q1 2026, an estimated $1.33M.
  • Edgestream Partners first reported a position in Labcorp in Q3 2016 and held it in 11 quarters.
  • Edgestream Partners's Labcorp position peaked at $6.95M in Q4 2020.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.